DCM and COVID-19 share overlapping pathogenic mechanisms that exacerbate cardiac injury, including ACE2 downregulation, maladaptive RAAS activation, and heightened inflammation. This evidence concerns the gene ACE2 and familial dilated cardiomyopathy.